Literature DB >> 11827922

Insulin causes endothelial dysfunction in humans: sites and mechanisms.

Guido Arcaro1, Anna Cretti, Sara Balzano, Alessandro Lechi, Michele Muggeo, Enzo Bonora, Riccardo C Bonadonna.   

Abstract

BACKGROUND: Insulin resistance is often accompanied by hyperinsulinemia and may predispose to atherosclerosis. Endothelium plays a central role in atherogenesis. The in vivo effects of hyperinsulinemia on endothelial function of large conduit arteries are unknown. METHODS AND
RESULTS: Twenty-five healthy subjects were enrolled for study. In study A (n=9), subjects underwent both a time-control saline study and a euglycemic low-dose insulin (insulin approximately 110 pmol/L) clamp for 6 hours. Study B (n=5) was identical to study A except that the euglycemic clamp was performed at high physiological insulin concentrations (approximately 440 pmol/L). In study C (n=7), subjects underwent two 4-hour euglycemic insulin (approximately 110 pmol/L) clamps with and without the concomitant infusion of an antioxidant (vitamin C). In study D (n=4), two saline time-control studies were performed with and without the concomitant infusion of vitamin C. In all studies, both at baseline and throughout the experimental period, endothelium-dependent (flow-mediated) and endothelium-independent (nitroglycerin-induced) vasodilation was assessed in femoral and brachial arteries by echo Doppler. Both low (study A) and high physiological (study B) hyperinsulinemia abolished endothelium-dependent vasodilation, whereas endothelium-independent vasodilation was unaffected. Vitamin C fully restored insulin-impaired endothelial function without affecting endothelium-independent vasodilation (study C). Vitamin C had no effects on endothelium-dependent or endothelium-independent vasodilation during saline control studies (study D).
CONCLUSIONS: Modest hyperinsulinemia, mimicking fasting hyperinsulinemia of insulin-resistant states, abrogates endothelium-dependent vasodilation in large conduit arteries, probably by increasing oxidant stress. These data may provide a novel pathophysiological basis to the epidemiological link between hyperinsulinemia/insulin-resistance and atherosclerosis in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11827922     DOI: 10.1161/hc0502.103333

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  101 in total

1.  Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus.

Authors:  A Chan; E J Barrett; S M Anderson; B P Kovatchev; M D Breton
Journal:  Diabetologia       Date:  2011-12-14       Impact factor: 10.122

2.  Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice.

Authors:  Christian Rask-Madsen; Erica Buonomo; Qian Li; Kyoungmin Park; Allen C Clermont; Oluwatobi Yerokun; Mark Rekhter; George L King
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-15       Impact factor: 8.311

Review 3.  Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication.

Authors:  Randy S Sprague; Mary L Ellsworth
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

4.  Hyperglycemic endothelial dysfunction: does it happen and does it matter?

Authors:  Robert P Hoffman
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

5.  Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition.

Authors:  Ioannis Akoumianakis; Ileana Badi; Gillian Douglas; Surawee Chuaiphichai; Laura Herdman; Nadia Akawi; Marios Margaritis; Alexios S Antonopoulos; Evangelos K Oikonomou; Costas Psarros; Nikolaos Galiatsatos; Dimitris Tousoulis; Attila Kardos; Rana Sayeed; George Krasopoulos; Mario Petrou; Uwe Schwahn; Paulus Wohlfart; Norbert Tennagels; Keith M Channon; Charalambos Antoniades
Journal:  Sci Transl Med       Date:  2020-04-29       Impact factor: 17.956

Review 6.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 7.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 8.  Preventing diabetes by treating aspects of the metabolic syndrome.

Authors:  Roopa Sathyaprakash; Robert R Henry
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 9.  Association of albuminuria and the metabolic syndrome.

Authors:  Kevin Rowley; Kerin O'Dea; James D Best
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 10.  Mechanisms of adverse cardiometabolic consequences of obesity.

Authors:  Carlos M Diaz-Melean; Virend K Somers; Juan Pablo Rodriguez-Escudero; Prachi Singh; Ondrej Sochor; Ernesto Manuel Llano; Francisco Lopez-Jimenez
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.